United States · FDA National Drug Code directory
Lisinopril and Hydrochlorothiazide
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 70518-0174_54eff74e-9342-7043-e063-6294a90a0f2e
- Product NDC
- 70518-0174
- Form
- TABLET
- Composition / generic term
- Lisinopril and Hydrochlorothiazide
- Labeler
- REMEDYREPACK INC.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20170123
- Source listing expiry
- 20271231
Source-listed ingredients
- HYDROCHLOROTHIAZIDE — 25 mg/1
- LISINOPRIL — 20 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 TABLET in 1 BOTTLE, PLASTIC (70518-0174-0) · 70518-0174-0
- 90 TABLET in 1 BOTTLE, PLASTIC (70518-0174-1) · 70518-0174-1
- 100 TABLET in 1 BOTTLE, PLASTIC (70518-0174-2) · 70518-0174-2
- 30 TABLET in 1 BLISTER PACK (70518-0174-3) · 70518-0174-3
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →